+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Influenza Diagnostic Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5125740
  • Report
  • July 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott Laboratories
  • Coris Bioconcept Sprl
  • F. Hoffmann-La Roche Ltd
  • Hologic
  • Quidel Corporation
  • Siemens Healthineers
Influenza Diagnostics Global Market Report 2020-30: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global influenza diagnostics market.

This report focuses on influenza diagnostics market which is experiencing strong growth. The report gives a guide to the influenza diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the influenza diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Influenza Diagnostics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider influenza diagnostics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The influenza diagnostics market section of the report gives context. It compares the influenza diagnostics market with other segments of the influenza diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, influenza diagnostics indicators comparison.
Scope

Markets Covered:
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Others
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests 3) By End User: Hospitals & Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd; Quidel Corporation; Тhеrmо Fіѕhеr; Abbott Laboratories; Hologic

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Coris Bioconcept Sprl
  • F. Hoffmann-La Roche Ltd
  • Hologic
  • Quidel Corporation
  • Siemens Healthineers
1. Executive Summary

2. Influenza Diagnostics Market Characteristics

3. Influenza Diagnostics Market Size and Growth
3.1. Global Influenza Diagnostics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Influenza Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Influenza Diagnostics Market Segmentation
4.1. Global Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Rapid influenza diagnostic tests (RIDT)
  • Viral Culture
  • DFA
  • Serological assays
  • Othes
4.2. Global Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Isothermal Nucleic Acid Amplification Tests (INAAT)
  • Loop Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Other Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Diagnostic Tests
4.3. Global Influenza Diagnostics Market, Segmentation by End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals & Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Other End Users
5. Influenza Diagnostics Market Regional and Country Analysis
5.1. Global Influenza Diagnostics Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Influenza Diagnostics Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Influenza Diagnostics Market
6.1. Asia-Pacific Influenza Diagnostics Market Overview
6.2. Asia-Pacific Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Influenza Diagnostics Market
7.1. China Influenza Diagnostics Market Overview
7.2. China Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Influenza Diagnostics Market
8.1. India Influenza Diagnostics Market Overview
8.2. India Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Influenza Diagnostics Market
9.1. Japan Influenza Diagnostics Market Overview
9.2. Japan Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Influenza Diagnostics Market
10.1. Australia Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Influenza Diagnostics Market
11.1. Indonesia Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Influenza Diagnostics Market
12.1. South Korea Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Influenza Diagnostics Market
13.1. Western Europe Influenza Diagnostics Market Overview
13.2. Western Europe Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Influenza Diagnostics Market
14.1. UK Influenza Diagnostics Market Overview
14.2. UK Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Influenza Diagnostics Market
15.1. Germany Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Influenza Diagnostics Market
16.1. France Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.2. France Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Influenza Diagnostics Market
17.1. Eastern Europe Influenza Diagnostics Market Overview
17.2. Eastern Europe Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Influenza Diagnostics Market
18.1. Russia Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Influenza Diagnostics Market
19.1. North America Influenza Diagnostics Market Overview
19.2. North America Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Influenza Diagnostics Market
20.1. USA Influenza Diagnostics Market Overview
20.2. USA Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Influenza Diagnostics Market
21.1. South America Influenza Diagnostics Market Overview
21.2. South America Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Influenza Diagnostics Market
22.1. Brazil Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Influenza Diagnostics Market
23.1. Middle East Influenza Diagnostics Market Overview
23.2. Middle East Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Influenza Diagnostics Market
24.1. Africa Influenza Diagnostics Market Overview
24.2. Africa Influenza Diagnostics Market, Segmentation by Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Influenza Diagnostics Market, Segmentation by Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Influenza Diagnostics Market Competitive Landscape and Company Profiles
25.1. Influenza Diagnostics Market Competitive Landscape
25.2. Influenza Diagnostics Market Company Profiles
25.2.1. F. Hoffmann-La Roche Ltd
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Quidel Corporation
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Тhеrmо Fіѕhеr
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Abbott Laboratories
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Hologic
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Influenza Diagnostics Market

27. Influenza Diagnostics Market Trends and Strategies

28. Influenza Diagnostics Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Coris Bioconcept Sprl
  • F. Hoffmann-La Roche Ltd
  • Hologic
  • Quidel Corporation
  • Siemens Healthineers
Major players in the influenza diagnostic market are F. Hoffmann-La Roche Ltd, Quidel Corporation, Тhеrmо Fіѕhеr, Abbott Laboratories, Hologic, Becton, Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., and GenMark Diagnostics.

The global influenza diagnostics market is expected to grow from $1.14 billion in 2019 to 1.31 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%. A significant increase is registered in 2020 due to the COVID 19 outbreak. The global pandemic which is expected to be there for some time and the upcoming flu season could place a tremendous burden on the healthcare system and result in many illnesses, hospitalizations and deaths. This is expected to drive the demand for more rapid detection diagnostic kits. Since COVID-19 and the flu are respiratory illnesses and can cause similar symptoms, the governments across the globe are making preparedness plans. For instance, the CDC is seeking emergency use authorization from the FDA for a new assay that can simultaneously detect SARS-CoV-2 and influenza. The market is then expected to stabilize and reach $1.43 billion in 2023 at a CAGR of 2.89%.

The influenza diagnostic market consists of sales of diagnostic tests used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting the diagnostics tests for influenza virus detection.

North America was the largest region in the global influenza diagnostics market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

In June 2019, Meridian Bioscience Inc., an international producer and distributor of a range of diagnostic test kits, completed its acquisition of GenePoc Inc., a Canadian provider of molecular diagnostic instruments and assays. Meridian will now include GenePOC’s state-of-the-art revogene molecular diagnostics platform, which offers samples to result in testing for single tests, as well as flexible multiplexing capability. GenePOC is a subsidiary of Debiopharm Group. It specializes in the development and commercialization of rapid molecular assays usable on the unique revogene platform for near-patient infectious disease diagnostic.

The influenza diagnostics market covered in this report is segmented by traditional diagnostic tests into rapid influenza diagnostic tests (RIDT); viral culture; DFA; serological assays; others. It is also segmented by molecular diagnostic tests into reverse transcription-polymerase chain reaction (rt-PCR); isothermal nucleic acid amplification tests (INAAT); loop-mediated isothermal based amplification assays; transcription-mediated isothermal based amplification assays; other isothermal nucleic acid amplification tests; other molecular diagnostic tests and by end-user into hospitals & clinical laboratories; diagnostic reference laboratories; academic/research institutes; other end-users.

The variability in sensitivity and specificity among the influenza diagnostic tests is restraining the growth of the market. In most rapid flu tests, there are difficulties in identifying patients with influenza. The sensitivity of rapid flu tests ranges from 10-80% across various patient populations. Most diagnostic tests show an increase in the rate of false-negative results during low influenza virus activity, which often leads to an incorrect diagnosis. Thus, the variability in sensitivity and specificity is restraining the growth of the influenza diagnostic market.

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

In 2018, Siemens Healthineers acquired Fast Track Diagnostics for an undisclosed amount. By introducing Fast Track Diagnostics products to its molecular diagnostics portfolio, Siemens Healthineers is investing in precision medicine and better patient experience through solutions that eliminate the need for repeat diagnostic testing, reducing time and improving patient outcomes. Fast Track Diagnostics specializes in the design, development and manufacture of infectious disease detection kits that use syndromic multiplex real-time PCR.

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations. Therefore, it is important to accelerate the pace of scientific research progress that can have the greatest public health impact. Many public and private health organizations, researchers, health professionals, biopharmaceutical companies have maximized the spending for research funds or grants to reduce the risk of the emergence of pandemic influenza. For instance, in 2019, the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, a new network of research centers that will work together to develop influenza vaccines. NIAID will provide up to approximately $51 million in total first-year funding for the program, which is designed to support the CIVICs program centers over seven years.
Note: Product cover images may vary from those shown
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Тhеrmо Fіѕhеr
  • Abbott Laboratories
  • Hologic
  • Becton, Dickinson and Company
  • DiaSorin S.p.A.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • GenMark Diagnostics
  • SA Scientific, Ltd.
  • Sekisui Diagnostics
  • bioMérieux Inc
  • Danaher Corporation
  • Siemens Healthineers
  • Coris Bioconcept Sprl
  • Mast Group
  • ELITech
  • Analytik Jena AG
  • altona Diagnostics GmbH
  • Tecan Trading AG
  • Genome Diagnostics
  • Germaine Laboratories
  • Response Biomedical
  • TAUNS Laboratories
  • TRUPCR
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll